Aclaris Therapeutics, Inc.
ACRS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001557746
No open-market purchases or sales by Aclaris Therapeutics, Inc. insiders were filed in the last 90 days; 148 institutions reported holding it in 13F filings for Q2 2026, worth $630.0M in total; no superinvestor holds it.
13F holders, Q2 2025
Institutional positions in Aclaris Therapeutics, Inc. as of Jun 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 96
- −13 vs. Q1 2025
- Shares held
- 91.9M
- −843.6K (−0.9%) vs. Q1 2025
- Total value
- $130.4M
- −$13.4M (−9.3%) vs. Q1 2025
- New holders
- 23
- 29 more added
- Sold out
- 36
- 29 more reduced
Compare with Q1 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ACRS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 148 | $630.0M |
| Q1 2026 | 136 | $409.4M |
| Q4 2025 | 122 | $252.1M |
| Q3 2025 | 103 | $162.8M |
| Q2 2025 | 96 | $130.4M |
| Q1 2025 | 109 | $143.8M |
| Q4 2024 | 98 | $217.0M |
| Q3 2024 | 81 | $58.5M |
| Q2 2024 | 98 | $58.1M |
| Q1 2024 | 98 | $67.5M |
| Q4 2023 | 107 | $61.4M |
| Q3 2023 | 138 | $480.0M |
| Q2 2023 | 133 | $737.2M |
| Q1 2023 | 149 | $579.3M |
| Q4 2022 | 128 | $1.04B |
| Q3 2022 | 127 | $1.00B |
| Q2 2022 | 115 | $883.3M |
| Q1 2022 | 110 | $1.02B |
| Q4 2021 | 133 | $814.9M |
| Q3 2021 | 126 | $1.02B |
| Q2 2021 | 128 | $983.4M |
| Q1 2021 | 97 | $1.14B |
Institutions, Q2 2025
Shares, value and share of portfolio for each institution holding Aclaris Therapeutics, Inc.; share changes are against Q1 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Walleye Capital LLC | 0 | $0 | 0.00% | −311,712−100.0% | Sold out |
| Man Group plc | 0 | $0 | 0.00% | −197,748−100.0% | Sold out |
| Graham Capital Management, L.P. | 0 | $0 | 0.00% | −177,558−100.0% | Sold out |
| Omers Administration Corp | 0 | $0 | 0.00% | −175,900−100.0% | Sold out |
| Ikarian Capital, LLC | 0 | $0 | 0.00% | −150,900−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −127,592−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −86,348−100.0% | Sold out |
| Alps Advisors Inc | 0 | $0 | 0.00% | −78,782−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −70,502−100.0% | Sold out |
| Jain Global LLC | 0 | $0 | 0.00% | −65,672−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −59,865−100.0% | Sold out |
| Boothbay Fund Management, LLC | 0 | $0 | 0.00% | −53,478−100.0% | Sold out |
| Quantessence Capital LLC | 0 | $0 | 0.00% | −51,664−100.0% | Sold out |
| LMR Partners LLP | 0 | $0 | 0.00% | −48,360−100.0% | Sold out |
| State of Wyoming | 0 | $0 | 0.00% | −46,861−100.0% | Sold out |
| Point72 Asia (Singapore) Pte. Ltd. | 0 | $0 | 0.00% | −45,659−100.0% | Sold out |
| Oxford Asset Management LLP | 0 | $0 | 0.00% | −41,723−100.0% | Sold out |
| Cannon Global Investment Management, LLC | 0 | $0 | 0.00% | −37,400−100.0% | Sold out |
| Verition Fund Management LLC | 0 | $0 | 0.00% | −35,805−100.0% | Sold out |
| Diametric Capital, LP | 0 | $0 | 0.00% | −30,137−100.0% | Sold out |
| Susquehanna Fundamental Investments, LLC | 0 | $0 | 0.00% | −29,316−100.0% | Sold out |
| SEI Investments Co | 0 | $0 | 0.00% | −25,189−100.0% | Sold out |
| Capstone Investment Advisors, LLC | 0 | $0 | 0.00% | −23,564−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −17,286−100.0% | Sold out |
| Catalyst Funds Management Pty Ltd | 0 | $0 | 0.00% | −16,698−100.0% | Sold out |
| Capula Management Ltd | 0 | $0 | 0.00% | −15,593−100.0% | Sold out |
| Commonwealth Equity Services, LLC | 0 | $0 | 0.00% | −14,694−100.0% | Sold out |
| Hudson Bay Capital Management LP | 0 | $0 | 0.00% | −12,200−100.0% | Sold out |
| Prelude Capital Management, LLC | 0 | $0 | 0.00% | −11,791−100.0% | Sold out |
| Brevan Howard Capital Management LP | 0 | $0 | 0.00% | −11,373−100.0% | Sold out |
| Point72 (DIFC) Ltd | 0 | $0 | 0.00% | −6,132−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −3,413−100.0% | Sold out |